People · Operator

Kris J. Meulen

Named in public records as an officer, director or promoter · active 2023–2025 · Other

1
Companies
2
Filings
$52.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Bonumose, Inc.OtherSeries C$52.1M$1.0M2023
Operator network

Kris J. Meulen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Edward Williams · 3 companies · 1 sharedEdward WilliamsAnthony J. DeLio III · 1 companies · 1 sharedAnthony J. DeLio …Charles J. Eggert · 1 companies · 1 sharedCharles J. EggertDaniel J. Wichelecki · 1 companies · 1 sharedDaniel J. Wichele…Edward J. Williams · 1 companies · 1 sharedEdward J. WilliamsEdwin O. Rogers · 1 companies · 1 sharedEdwin O. RogersEdwin Rogers · 1 companies · 1 sharedEdwin RogersMichael J. Kime · 1 companies · 1 sharedMichael J. KimeMichael J. Salerno · 1 companies · 1 sharedMichael J. SalernoRobert J. Sproull · 1 companies · 1 sharedRobert J. SproullRobert Sproull · 1 companies · 1 sharedRobert SproullSteve J. Arrick · 1 companies · 1 sharedSteve J. ArrickTakashi J. Kuriki · 1 companies · 1 sharedTakashi J. KurikiTakashi Kuriki · 1 companies · 1 sharedTakashi KurikiBonumose, Inc. · $52.1M raisedBonumose, Inc.Kris J. MeulenKM
Kris J. Meulen Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Kris J. Meulen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Edward Williams13
Anthony J. DeLio III11
Edwin O. Rogers11
Daniel J. Wichelecki11
Steve J. Arrick11
Michael J. Salerno11
Robert J. Sproull11
Edward J. Williams11
Takashi J. Kuriki11
Michael J. Kime11
Charles J. Eggert11
Takashi Kuriki11
Edwin Rogers11
Robert Sproull11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.